UK Veterinary Vaccines Market Poised for Strong Growth

Published On : 2016-11-17

Veterinary vaccines have been used for maintaining the health and well-being of veterinary animals for a long time now. To protect animals against various contagious diseases and develop their immunity against a range of health conditions, vaccination is an effective line of defence.

Moreover, a number of animal diseases also tend to infect humans through zoonosis. Vaccines thus protect human health in addition to protecting animals, improving the quality of livestock for catering to growing demand of food. Another vital benefit vaccination offers is that it reduces the need for antibiotics for companion animals and food, to a remarkably low level. It is thus important to make vaccination a part of your animals’ health regime. Whether you own farm animals or pets, it is critical to have them vaccinated for a healthy, long life.

The Expanse of Veterinary Vaccines Market

Over the last few decades, the awareness of vaccination has improved and a large population has realised the significance of vaccinating their animals. As a result, the veterinary vaccination market has gained momentum in the recent past and is heading toward substantial growth in the near future.

Coming to the global market of veterinary vaccines, Europe is a clear dominator, with UK as a major respondent. Contributing a hefty amount to the total revenues, UK is closely followed by US. UK has lately grown into a large market for veterinary vaccines in response to rising pet population, increased awareness, burgeoning prevalence of diseases in animals, and frequent occurrences of zoonotic diseases in humans. To help fight this scenario, vaccination companies are introducing new, innovative vaccines. Government entities also seem to augment their investment in the market, which in turn is adding up to the growth of market.

Key Factors Shaping for Growth of UK’s Market

  • Frequently changing disease patterns among animals
  • Increasing vulnerability of animals to chronic and fatal diseases
  • Improved resistance to latest administered vaccines
  • Growing consciousness against the use of conventional antimicrobials

All these factors are together driving UK’s veterinary vaccines market. However, a set of challenges is always there to hinder the growth of market. While the costs of maintenance and storage of already manufactured vaccines are sky high, the economic conditions on the other hand are slowing down the growth of the market.

Opportunities and Challenges in UK Veterinary Vaccines Market

The UK veterinary vaccines market has three distinct segments based on which it moves ahead. Diseases, products, and technology being the three key segments, the market is further segmented at the veterinary vaccination products viz. companion animal vaccines, livestock, poultry, equine, porcine, aquaculture, and other animal vaccines. Out of these sub-segments, none else but the companion animal vaccines form the fastest-growing one. The most influencing vaccine technologies include live attenuated, inactivated, conjugate, toxoid, recombinant, DNA, and subunit vaccines.

The UK market is gradually moving toward embracing next-generation technologies and trends for developing and delivering highly effective vaccines directed to existing as well as newly emerging animal diseases. A recent study identified a few challenges in the way to novel vaccine development, including antibacterial, antiparasitic, antiviral, and DNA vaccines. With persistent efforts however, the UK livestock industry can potentially improve in each aspect.

Vaccines are undoubtedly one of the most cost-effective ways and an efficient weapon in the arsenal against animal diseases. Recognising the power of vaccination in the evolving technological world, UK’s vaccines market is smartly capitalising on the opportunities.